Ottawa, May 12, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, welcomes Quebec’s new Life Sciences Strategy. This strategy is a critical step towards improving […]
Ottawa, April 28, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement in response to the Ontario budget released by Finance Minister Peter Bethlenfalvy today. […]
Ottawa, April 20, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement in response to the Federal Government’s recent announcement on the […]
IMC is pleased with the ongoing commitments to increased access to innovative medicines and treatments […]
Ottawa, March 31, 2022 – Innovative Medicines Canada (IMC) is disappointed by the latest Patented Medicine Prices Review Board (PMPRB) Annual Report, which continues to disseminate inaccurate representation of data […]
IMC welcomes the federal government’s renewed commitment to enhancing access […]
IMC is encouraged by the Quebec budget’s emphasis on life sciences, healthcare, and innovation […]
IMC is saddened and dismayed by Russia’s unprovoked invasion of Ukraine. […]
Ottawa, February 7, 2022 – COVID-19 vaccines have proven to be the most effective tool against the serious health impacts of COVID-19. Innovative Medicines Canada (IMC) and its member companies recognize […]
The HRF awarded its prestigious Medal of Honour […]
